FIELD: biotechnology, genetic engineering. SUBSTANCE: BDNF protein eliciting the neutropic activity is obtained by mammal cells culturing, in part, cells of the strain COS transformed with an expression vector PCMYI-PBDNF. Vector contains DNA fragment encoding the indicated protein. Nucleotide sequence of human, rat, pig and chicken DNA fragment is determined. BDNF protein has molecular mass 12 kDa, isoelectric point 9.9 and able to support viability of oral radix neuron ganglions, dopaminergic and cholinergic central nervous system neurons and inhibit the differentiation of astroglial cells. BDNF protein can be used for diagnosis and treatment of patients with different neurological disorders. EFFECT: improved method of protein preparing. 6 cl, 37 dwg, 12 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
ISOLATED DNA FRAGMENT, A METHOD OF PREPARING A RECOMBINANT PROTEIN EXHIBITING NEUROTROPIC ACTIVITY, PROTEIN NT-3 AND A PHARMACEUTICAL COMPOSITION | 1990 |
|
RU2128226C1 |
METHOD OF SYNTHESIS OF POLYPEPTIDE, HYBRID DNA (VARIANTS), FUSION PROTEIN (VARIANTS) | 1991 |
|
RU2120475C1 |
RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) WITHOUT ADDITIONAL METHIONINE RESIDUE AT N-TERMINUS | 1991 |
|
RU2108386C1 |
PROMOTER FOR SPECIFIC TRANSGENE EXPRESSION IN PLANT EPIDERMIS | 2004 |
|
RU2382079C2 |
MUTANT CHANNEL RHODOPSIN-2 | 2011 |
|
RU2595384C2 |
TUBERCULOSIS VACCINE WITH IMPROVED STRENGTH | 2004 |
|
RU2342400C2 |
SMALL RNA MOLECULES, MEDIATING RNA INTERFERENCE | 2007 |
|
RU2470073C2 |
SMALL RNA MOLECULES MEDIATING RNA INTERFERENCE | 2001 |
|
RU2322500C2 |
DNA (VARIANTS), METHOD FOR PREPARING PROTEIN, PROTEIN, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2208638C2 |
TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNF | 2013 |
|
RU2661104C2 |
Authors
Dates
1999-06-20—Published
1990-08-29—Filed